Skip to content
★ Sign in to follow
FM

Franklin Milan Berger

ESSA Pharma Inc.
Total declarations
33
Company
1
▲ Purchases (21 ops.)
€2.3M
▼ Sales (7 ops.)
€504k

Latest filing published 22 Nov 2023 for ESSA Pharma Inc., €90k.

Filing timeline

BuySale
Franklin Milan Berger

Insider track record

Disclosed buys
21
Disclosed sells
7
Signal history

Franklin Milan Berger: trading record in brief

This profile gathers the share dealings of Franklin Milan Berger in ESSA Pharma Inc. Over a trading history stretching from 9 January 2018 to 21 November 2023, the count stands at 33 filings.

In open-market terms, that means 21 purchases worth €2.3M on one side and 7 sales worth €504k on the other. The net balance comes to €1.8M on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2023, the count stands at 3 purchases and 7 sales.

A typical purchase (the median) is worth €46k. Across 16 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 22 November 2023, reports an open-market purchase of €90k in ESSA Pharma Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Franklin Milan Berger

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations33 total
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    134,821 CAD15SEDI
    23,529 shares@ CA$5.732.0% of flowCommon SharesTSXSEDI:4212518
    Canonical exit: 19 Feb 2024 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    321,240 CAD11SEDI
    60,000 shares@ CA$5.3544.8% of flowCommon SharesTSXSEDI:4206861
    Canonical exit: 31 Jan 2024 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    98,661 CAD13SEDI
    16,471 shares@ CA$5.991.5% of flowCommon SharesTSXSEDI:4206863
    Canonical exit: 1 Feb 2024 (T+90)
  • ▼
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    143,000 CAD11SEDI
    50,000 shares@ CA$2.864.9% of flowCommon SharesTSXSEDI:4056480
  • ▼
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    91,312 CAD11SEDI
    37,889 shares@ CA$2.413.1% of flowCommon SharesTSXSEDI:4056483
  • ▼
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    133,500 CAD11SEDI
    50,000 shares@ CA$2.674.5% of flowCommon SharesTSXSEDI:4056481
  • ▼
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    83,088 CAD11SEDI
    34,334 shares@ CA$2.422.8% of flowCommon SharesTSXSEDI:4056484
  • ▼
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    110,351 CAD11SEDI
    43,617 shares@ CA$2.533.7% of flowCommon SharesTSXSEDI:4056482
  • ▼
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    75,000 CAD11SEDI
    25,000 shares@ CA$3.002.6% of flowCommon SharesTSXSEDI:4056478
  • ▼
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    92,800 CAD11SEDI
    32,000 shares@ CA$2.903.1% of flowCommon SharesTSXSEDI:4056479
  • ●
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    2M CAD18SEDI
    57,000 shares@ CA$27.0065.7% of flowCommon SharesTSXSEDI:3692935
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    349,280 CAD0SEDI
    50,000 shares@ CA$6.9856Common SharesTSXSEDI:3593176
    Canonical exit: 17 Nov 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    171,025 CAD0SEDI
    24,088 shares@ CA$7.10Common SharesTSXSEDI:3593180
    Canonical exit: 19 Nov 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    138,371 CAD0SEDI
    19,529 shares@ CA$7.0854Common SharesTSXSEDI:3593178
    Canonical exit: 18 Nov 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    680,000 CAD0SEDI
    100,000 shares@ CA$6.80Common SharesTSXSEDI:3591814
    Canonical exit: 15 Nov 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    47,600 CAD0SEDI
    7,000 shares@ CA$6.80Common SharesTSXSEDI:3591812
    Canonical exit: 15 Nov 2020 (T+90)
  • ●
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    600,000 CAD18SEDI
    100,000 shares@ CA$6.0011.3% of flowCommon SharesTSXSEDI:3583353
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    4,584 CAD17SEDI
    916 shares@ CA$5.00490.1% of flowCommon SharesTSXSEDI:3506790
    Canonical exit: 31 May 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    67,685 CAD17SEDI
    14,094 shares@ CA$4.80241.5% of flowCommon SharesTSXSEDI:3506788
    Canonical exit: 31 May 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    805,860 CAD19SEDI
    150,000 shares@ CA$5.372419.1% of flowCommon SharesTSXSEDI:3500183
    Canonical exit: 19 May 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    270,000 CAD18SEDI
    50,000 shares@ CA$5.406.4% of flowCommon SharesTSXSEDI:3500184
    Canonical exit: 20 May 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    158,764 CAD17SEDI
    29,565 shares@ CA$5.373.8% of flowCommon SharesTSXSEDI:3500181
    Canonical exit: 19 May 2020 (T+90)
  • ●
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    0SEDI
    273,843 sharesCommon SharesTSXSEDI:3485896
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    32,255 CAD18SEDI
    7,000 shares@ CA$4.607934.0% of flowCommon SharesTSXSEDI:3443390
    Canonical exit: 29 Jan 2020 (T+90)
  • ▲
    4 - Director of IssuerExecutivesESSA Pharma Inc.
    7,154 CAD12SEDI
    2,000 shares@ CA$3.5777.6% of flowCommon SharesTSXSEDI:3440587
    Canonical exit: 15 Jan 2020 (T+90)

25 of 33 declarations